Parkinson's disease

News

Regeneron joins Koneksa Parkinson's digital biomarker study

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patient

News

Jacob Simmering, PhD, University of Iowa assistant professor of internal medicine

Prostate drugs may find role in dementia, say US scientists

Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s, but is just as devastating, so the discovery that commonly used drugs may reduce the risk of the di

News

Blood test could spot Parkinson’s years earlier

An artificial intelligence-powered blood test that may be able to predict Parkinson’s disease several years before symptoms start to develop could allow earlier treatment and help guide the

News

US Congress passes bill to end Parkinson’s disease

The US Senate has joined the House of Representatives in approving the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for

News

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Anglo-US biotech NodThera has named former Jazz Pharma executive Dan Swisher as its new chief executive, replacing Alan Watt, who will take on the dual roles of president

News

FDA competition seeks digital endpoints for Parkinson’s

The FDA is asking digital health technology developers to come up with a solution to measuring a common symptom of Parkinson’s disease that can have a serious impact on pa

Regeneron joins Koneksa Parkinson's digital biomarker study

Prostate drugs may find role in dementia, say US scientists

Blood test could spot Parkinson’s years earlier

US Congress passes bill to end Parkinson’s disease

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

FDA competition seeks digital endpoints for Parkinson’s

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

Parkinson's disease

Editor's Picks